
### [NCIT:C8984](http://purl.obolibrary.org/obo/NCIT_C8984)
**Label:** Female Reproductive System Adenofibroma

**Subclasses:** [NCIT:C8979](http://purl.obolibrary.org/obo/NCIT_C8979) (Mucinous Cystadenofibroma), [NCIT:C67090](http://purl.obolibrary.org/obo/NCIT_C67090) (Serous Adenofibroma), [NCIT:C8978](http://purl.obolibrary.org/obo/NCIT_C8978) (Mucinous Adenofibroma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), [NCIT:C40069](http://purl.obolibrary.org/obo/NCIT_C40069) (Borderline Ovarian Endometrioid Adenofibroma), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40040](http://purl.obolibrary.org/obo/NCIT_C40040) (Ovarian Mucinous Adenofibroma), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C27289](http://purl.obolibrary.org/obo/NCIT_C27289) (Borderline Ovarian Endometrioid Cystadenofibroma), [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C8988](http://purl.obolibrary.org/obo/NCIT_C8988) (Clear Cell Cystadenofibroma), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C8986](http://purl.obolibrary.org/obo/NCIT_C8986) (Papillary Adenofibroma), [NCIT:C8987](http://purl.obolibrary.org/obo/NCIT_C8987) (Clear Cell Adenofibroma), [NCIT:C8985](http://purl.obolibrary.org/obo/NCIT_C8985) (Cystadenofibroma), [NCIT:C40113](http://purl.obolibrary.org/obo/NCIT_C40113) (Fallopian Tube Serous Adenofibroma), [NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma), [NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma), [NCIT:C126478](http://purl.obolibrary.org/obo/NCIT_C126478) (Broad Ligament Serous Adenofibroma), [NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma), [NCIT:C126477](http://purl.obolibrary.org/obo/NCIT_C126477) (Broad Ligament Serous Cystadenofibroma), [NCIT:C40031](http://purl.obolibrary.org/obo/NCIT_C40031) (Ovarian Serous Adenofibroma), [NCIT:C126311](http://purl.obolibrary.org/obo/NCIT_C126311) (Ovarian Seromucinous Adenofibroma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C37115](http://purl.obolibrary.org/obo/NCIT_C37115) (Serous Adenocarcinoma Cell) 53.12%
- [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C36773](http://purl.obolibrary.org/obo/NCIT_C36773) (Adenocarcinoma Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36794](http://purl.obolibrary.org/obo/NCIT_C36794) (Dysplastic Glandular Cell) and [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 53.12%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C3718](http://purl.obolibrary.org/obo/NCIT_C3718) (Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37179](http://purl.obolibrary.org/obo/NCIT_C37179) (Neoplastic Myeloblast without Azurophilic Granules))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37178](http://purl.obolibrary.org/obo/NCIT_C37178) (Neoplastic Myeloblast with Azurophilic Granules))) 38.48%
- [NCIT:C37114](http://purl.obolibrary.org/obo/NCIT_C37114) (Neoplastic Serous Epithelial Cell) and (not ([NCIT:C37177](http://purl.obolibrary.org/obo/NCIT_C37177) (Neoplastic Medium-Sized Myeloblast with Basophilic Agranular Cytoplasm))) 38.48%


